Insulet Corp (PODD)
244.98
+5.88
(+2.46%)
USD |
NASDAQ |
Nov 07, 16:00
250.22
+5.24
(+2.14%)
After-Hours: 20:00
Insulet Revenue (TTM): 1.873B for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.873B |
| March 31, 2024 | 1.781B |
| December 31, 2023 | 1.697B |
| September 30, 2023 | 1.557B |
| June 30, 2023 | 1.465B |
| March 31, 2023 | 1.368B |
| December 31, 2022 | 1.305B |
| September 30, 2022 | 1.243B |
| June 30, 2022 | 1.178B |
| March 31, 2022 | 1.142B |
| December 31, 2021 | 1.099B |
| September 30, 2021 | 1.037B |
| June 30, 2021 | 995.60M |
| March 31, 2021 | 958.70M |
| December 31, 2020 | 904.40M |
| September 30, 2020 | 867.70M |
| June 30, 2020 | 825.80M |
| March 31, 2020 | 776.60M |
| December 31, 2019 | 738.20M |
| September 30, 2019 | 693.68M |
| June 30, 2019 | 652.66M |
| March 31, 2019 | 599.82M |
| December 31, 2018 | 563.80M |
| September 30, 2018 | 529.47M |
| June 30, 2018 | 500.17M |
| Date | Value |
|---|---|
| March 31, 2018 | 485.66M |
| December 31, 2017 | 463.80M |
| September 30, 2017 | 436.82M |
| June 30, 2017 | 409.92M |
| March 31, 2017 | 387.49M |
| December 31, 2016 | 366.99M |
| September 30, 2016 | 347.22M |
| June 30, 2016 | 323.74M |
| March 31, 2016 | 296.96M |
| December 31, 2015 | 263.89M |
| September 30, 2015 | 195.25M |
| June 30, 2015 | 198.85M |
| March 31, 2015 | 210.31M |
| December 31, 2014 | 231.32M |
| September 30, 2014 | 284.69M |
| June 30, 2014 | 270.81M |
| March 31, 2014 | 258.89M |
| December 31, 2013 | 247.08M |
| September 30, 2013 | 236.38M |
| June 30, 2013 | 230.03M |
| March 31, 2013 | 220.97M |
| December 31, 2012 | 211.37M |
| September 30, 2012 | 200.73M |
| June 30, 2012 | 190.58M |
| March 31, 2012 | 171.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
738.20M
Minimum
Dec 2019
1.873B
Maximum
Jun 2024
1.201B
Average
1.142B
Median
Mar 2022
Revenue (TTM) Benchmarks
| Baxter International Inc | 15.00B |
| Boston Scientific Corp | 15.91B |
| Abbott Laboratories | 41.22B |
| Globus Medical Inc | 2.479B |
| Bioventus Inc | 555.06M |